Swedegene is currently collecting the following adverse drug reactions. More adverse drug reactions will be added to the initial list as the project proceeds and may involve any type.

• Angioedema related to ACE-inhibitors/ARBs.
• Cough related to ACE-inhibitors.
• Osteonecrosis and atypical fractures due to bisphosphonates.
• Phototoxic reactions due to topical NSAIDS and fluoroquinolones.
• Hypersensitivity, mainly to antibiotics and NSAIDs.
• Metabolic reactions from neuroleptics and antidepressants.
• Hyponatremia/SIADH due to antidepressants and antiepileptics.
• CNS toxicity and neuropsychiatric reactions from antiviral therapy and antibiotics.
• Stevens-Johnson syndrome/Toxic epidermal necrolysis.
• Mefloquine-induced psychiatric reactions.
• Tendon-rupture from flouroquinolones.
• Liver toxicity.
• Torsade de Pointes/QT-prolongation.
• Agranulocytosis.
• Rhabdomyolysis and myopahty due to lipid-lowering drugs.
• Rhabdomyolysis related to statins/fibrates.
• Narcolepsy associated with Pandemrix.
• Hearing impairment from aminoglycosides.
• Pancreatitis.
• Thrombocytopenia.
• Renal toxicity.
• Hair loss (alopecia).
• Bleeding due to new oral anticoagulants (NOAC).